Bisphosphonate-Induced Cutaneous Adverse Events: The Difficulty of Assessing Imputability through Patch Testing

Publisher： Karger

E-ISSN： 1421-9832|229|3|163-168

ISSN： 1018-8665

Source： Dermatology, Vol.229, Iss.3, 2014-10, pp. : 163-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma

By  

Dermatology, Vol. 208, Iss. 1, 2004-02 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Cutaneous Adverse Events of Biological Therapy for Psoriasis: Review of the Literature

By  

Dermatology, Vol. 211, Iss. 3, 2005-11 ,pp. : 209-217

Karger

Access to resources Recommend Favorite

Patch-Test-Induced Subjective Complaints

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Cutaneous Pseudolymphoma Induced by Cimicifuga racemosa

By  

Dermatology, Vol. 214, Iss. 1, 2006-12 ,pp. : 94-96

Karger

Access to resources Recommend Favorite

Cutaneous Adverse Drug Reaction to Oral Acetazolamide and Skin Tests

By  

Dermatology, Vol. 226, Iss. 4, 2013-06 ,pp. : 347-352

Karger

Access to resources Recommend Favorite